Protara Therapeutics (TARA)

• Market cap: $201M
• 1 day: 2.16%
• 5 days: 0.19%
• 1 month: 17.91%
• 3 months: 56.16%
• 6 months: 52.94%
• Year to date: -6.81%
• 1 year: 122.22%
• 5 years: -72.13%
• 10 years: -99.05%
• Sector: Healthcare
• Industry: Biotechnology

About: Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

Employees: 33